Inventor · disambiguated record
Manuela Campana
Also filed as: CAMPANA MANUELA
22 granted patents·26 pending applications·543 citations·filing 2003–2022
97Inventor score
Files withALFA WASSERMANN SPA20VISCOMI GIUSEPPE CLAUDIO13ALFASIGMA SPA12SALIX PHARMACEUTICALS LTD2SALIX PHARMACEUTICALS INC1
Top patents by PatentIndex Score
48 records- 0197US8158781B2Polymorphic forms α, β and γ of rifaximinVISCOMI GIUSEPPE CLAUDIO·Filed 2011·Granted Apr 17, 2012·27 cites·8 claims
- 0297US7902206B2Polymorphic forms α, β and γ of rifaximinALFA WASSERMANN SPA·Filed 2008·Granted Mar 8, 2011·28 cites·57 claims
- 0397US7045620B2Polymorphous forms of rifaximin, processes for their production and use thereof in medicinal preparationsALFA WASSERMANN SPA·Filed 2003·Granted May 16, 2006·139 cites·20 claims
- 0496US8835452B2Polymorphic forms α, β and γ of rifaximinALFA WASSERMANN SPA·Filed 2012·Granted Sep 16, 2014·15 cites·21 claims
- 0596US8193196B2Polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparationsVISCOMI GIUSEPPE CLAUDIO·Filed 2006·Granted Jun 5, 2012·40 cites·24 claims
- 0696US7915275B2Use of polymorphic forms of rifaximin for medical preparationsALFA WASSERMANN SPA·Filed 2007·Granted Mar 29, 2011·53 cites·30 claims
- 0796US7906542B2Pharmaceutical compositions comprising polymorphic forms α, β, and γ of rifaximinALFA WASSERMANN SPA·Filed 2008·Granted Mar 15, 2011·40 cites·25 claims
- 0895US8741904B2Polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparationsALFA WASSERMANN SPA·Filed 2013·Granted Jun 3, 2014·20 cites·44 claims
- 0995US8518949B2Polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparationsVISCOMI GIUSEPPE CLAUDIO·Filed 2012·Granted Aug 27, 2013·25 cites·21 claims
- 1095US8158644B2Pharmaceutical compositions comprising polymorphic forms α, β, and γ of rifaximinVISCOMI GIUSEPPE CLAUDIO·Filed 2011·Granted Apr 17, 2012·26 cites·20 claims
- 1195US7923553B2Processes for the production of polymorphic forms of rifaximinALFA WASSERMANN SPA·Filed 2008·Granted Apr 12, 2011·18 cites·46 claims
- 1295US7612199B2Polymorphic forms α, β, and γ of rifaximinALFA WASSERMANN SPA·Filed 2009·Granted Nov 3, 2009·45 cites·7 claims
- 1394US9271968B2Polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparationsALFA WASSERMANN SPA·Filed 2014·Granted Mar 1, 2016·14 cites·18 claims
- 1493US8853231B2Pharmaceutical compositions comprising polymorphic forms α, β, and γ of rifaximinALFA WASSERMANN SPA·Filed 2012·Granted Oct 7, 2014·15 cites·18 claims
- 1592US8173801B2Processes for the production of polymorphic forms of rifaximinVISCOMI GIUSEPPE CLAUDIO·Filed 2011·Granted May 8, 2012·14 cites·19 claims
- 1690US8404704B2Use of polymorphic forms of rifaximin for medical preparationsVISCOMI GIUSEPPE CLAUDIO·Filed 2011·Granted Mar 26, 2013·12 cites·15 claims
- 1784US9364467B2Rifaximin derivative and uses thereofSALIX PHARMACEUTICALS LTD·Filed 2015·Granted Jun 14, 2016·4 cites·8 claims
- 1880US2022119403A1Polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparationsALFASIGMA SPA·Filed 2021·Application pending·0 cites
- 1980US2022127283A1Polymorphic forms alpha, beta and gamma of rifaximinALFASIGMA SPA·Filed 2022·Application pending·0 cites
- 2079US8318763B2Rifamycin derivativesVISCOMI GIUSEPPE CLAUDIO·Filed 2009·Granted Nov 27, 2012·5 cites·19 claims
- 2174US9725466B2Rifaximin derivative and uses thereofSALIX PHARMACEUTICALS INC·Filed 2016·Granted Aug 8, 2017·1 cites·20 claims
- 2273US10703763B2Polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparationsALFASIGMA SPA·Filed 2019·Granted Jul 7, 2020·0 cites·9 claims
- 2373US2020339599A1Polymorphic forms alpha, beta and gamma of rifaximinALFASIGMA SPA·Filed 2020·Application pending·0 cites
- 2473US2019263829A1Polymorphic forms alpha, beta and gamma of rifaximinALFASIGMA SPA·Filed 2019·Application pending·0 cites
- 2573US2020277301A1Polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparationsALFASIGMA SPA·Filed 2020·Application pending·0 cites
- 2673US2020339600A1Pharmaceutical compositions comprising polymorphic forms alpha, beta, and gamma of rifaximinALFASIGMA SPA·Filed 2020·Application pending·0 cites
- 2772US9035046B2Rifaximin derivative and uses thereofSALIX PHARMACEUTICALS LTD·Filed 2014·Granted May 19, 2015·1 cites·3 claims
- 2872US2015175627A1Polymorphic forms alpha, beta and gamma of rifaximinALFA WASSERMANN SPA·Filed 2014·Application pending·0 cites
- 2971US2019263830A1Pharmaceutical compositions comprising polymorphic forms alpha, beta, and gamma of rifaximinALFASIGMA SPA·Filed 2019·Application pending·0 cites
- 3070US2019135831A1Polymorphic forms alpha, beta and gamma of rifaximinALFASIGMA SPA·Filed 2018·Application pending·0 cites
- 3168US2019135830A1Pharmaceutical compositions comprising polymorphic forms alpha, beta, and gamma of rifaximinALFASIGMA SPA·Filed 2018·Application pending·0 cites
- 3267US8765778B2Rifamycin derivativesALFA WASSERMANN SPA·Filed 2012·Granted Jul 1, 2014·1 cites·29 claims
- 3367US2018065987A1Polymorphic forms alpha, beta and gamma of rifaximinALFA WASSERMANN SPA·Filed 2017·Application pending·0 cites
- 3467US2008262024A1Rifaximin compositions and method of useVISCOMI GIUSEPPE CLAUDIO·Filed 2008·Application pending·0 cites
- 3567US2015182508A1Pharmaceutical compositions comprising polymorphic forms alpha, beta, and gamma of rifaximinALFA WASSERMANN SPA·Filed 2014·Application pending·0 cites
- 3666US2018291032A1Polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparationsALFASIGMA SPA·Filed 2017·Application pending·0 cites
- 3766US2012203000A1Polymorphic forms alpha, beta and gamma of rifaximinVISCOMI GIUSEPPE CLAUDIO·Filed 2012·Application pending·0 cites
- 3866US2017210758A1Polymorphic forms alpha, beta and gamma of rifaximinALFA WASSERMANN SPA·Filed 2016·Application pending·0 cites
- 3965US2018065988A1Pharmaceutical compositions comprising polymorphic forms alpha, beta, and gamma of rifaximinALFA WASSERMANN SPA·Filed 2017·Application pending·0 cites
- 4063US2017210757A1Pharmaceutical compositions comprising polymorphic forms alpha, beta, and gamma of rifaximinALFA WASSERMANN SPA·Filed 2016·Application pending·0 cites
- 4162US2012202989A1Pharmaceutical compositions comprising polymorphic forms alpha, beta, and gamma of rifaximinVISCOMI GIUSEPPE CLAUDIO·Filed 2012·Application pending·0 cites
- 4261US2016362419A1Polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparationsALFA WASSERMANN SPA·Filed 2016·Application pending·0 cites
- 4358US2005272754A1Polymorphic forms of rifaximin, processes for their production and uses thereofALFA WASSERMANN SPA·Filed 2005·Application pending·0 cites
- 4457US2012258166A1Rifaximin compositions and method of useVISCOMI GIUSEPPE CLAUDIO·Filed 2012·Application pending·0 cites
- 4557US2022119410A1Pharmaceutical compositions comprising polymorphic forms alpha, beta, and gamma of rifaximinALFASIGMA SPA·Filed 2021·Application pending·0 cites
- 4656US2012035202A1Rifaximin compositions and method of useVISCOMI GIUSEPPE CLAUDIO·Filed 2011·Application pending·0 cites
- 4754US2012214989A1Processes for the production of polymorphic forms of rifaximinVISCOMI GIUSEPPE CLAUDIO·Filed 2012·Application pending·0 cites
- 4854US2011086871A1Rifaximin compositions and method of useALFA WASSERMANN SPA·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Manuela Campana files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →